Immunobridging remains a feasible way of determining vaccine efficacy, even if the US does not yet have an official stance on the matter, the Ministry of Health and Welfare said yesterday.
The Food and Drug Administration (FDA) on Thursday last week said it would adopt the alternative approach in lieu of phase 3 trial data when evaluating emergency use authorization (EUA) for locally developed COVID-19 vaccines.
Immunobridging compares the efficacy of an approved vaccine with a trial one by measuring the concentration of neutralizing antibodies in each group of recipients.
Photo courtesy of the Executive Yuan
For a domestic vaccine to be approved, those who received the vaccine in phase 2 trials must present an antibody concentration at least as high as that found in 200 Taiwanese who have received both doses of the AstraZeneca vaccine.
Immunobridging was proposed by the WHO earlier this year and is supported by the EU, South Korea and other nations, Minister of Health and Welfare Chen Shih-chung (陳時中) said last week, although he also acknowledged that no other countries have issued this type of EUA.
However, local media have questioned international acceptance of the method, citing a statement from the US FDA.
The US regulator made the comment in response to an inquiry sent on May 20 by the Center for Drug Evaluation about the feasibility of immunobridging replacing phase 3 trials, the Chinese-language United Daily News reported.
In the message, the US FDA said an official position is not yet available, as it is “still discussing approaches to immunobridging,” the newspaper said, calling it a “slap in the face” and clear reproach of the method.
Centers for Disease Control (CDC) Deputy Director-General Chuang Jen-hsiang (莊人祥) yesterday confirmed that the CDC sent messages to US, Japanese, EU and other health authorities seeking their opinions on immunobridging.
However, the current controversy is only a matter of differing interpretations, he told reporters at the daily COVID-19 pandemic briefing.
The US regulator was unable to respond because it has not yet reached a clear conclusion, he said.
Washington was also relatively conservative about the method during a WHO meeting on May 26, but the UK, South Korea and other nations said they would accept it, while the EU voiced conditional approval, Chuang added.
Deputy Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) also weighed in, telling reporters after an Executive Yuan meeting that Washington cannot have an official stance because it is still discussing the matter.
However, this does not negate the method’s feasibility, Hsueh added.
Additional reporting by CNA
Taipei, New Taipei City, Keelung and Taoyuan would issue a decision at 8pm on whether to cancel work and school tomorrow due to forecasted heavy rain, Keelung Mayor Hsieh Kuo-liang (謝國樑) said today. Hsieh told reporters that absent some pressing reason, the four northern cities would announce the decision jointly at 8pm. Keelung is expected to receive between 300mm and 490mm of rain in the period from 2pm today through 2pm tomorrow, Central Weather Administration data showed. Keelung City Government regulations stipulate that school and work can be canceled if rain totals in mountainous or low-elevation areas are forecast to exceed 350mm in
EVA Airways president Sun Chia-ming (孫嘉明) and other senior executives yesterday bowed in apology over the death of a flight attendant, saying the company has begun improving its health-reporting, review and work coordination mechanisms. “We promise to handle this matter with the utmost responsibility to ensure safer and healthier working conditions for all EVA Air employees,” Sun said. The flight attendant, a woman surnamed Sun (孫), died on Friday last week of undisclosed causes shortly after returning from a work assignment in Milan, Italy, the airline said. Chinese-language media reported that the woman fell ill working on a Taipei-to-Milan flight on Sept. 22
COUNTERMEASURE: Taiwan was to implement controls for 47 tech products bound for South Africa after the latter downgraded and renamed Taipei’s ‘de facto’ offices The Ministry of Foreign Affairs is still reviewing a new agreement proposed by the South African government last month to regulate the status of reciprocal representative offices, Minister of Foreign Affairs Lin Chia-lung (林佳龍) said yesterday. Asked about the latest developments in a year-long controversy over Taiwan’s de facto representative office in South Africa, Lin during a legislative session said that the ministry was consulting with legal experts on the proposed new agreement. While the new proposal offers Taiwan greater flexibility, the ministry does not find it acceptable, Lin said without elaborating. The ministry is still open to resuming retaliatory measures against South
1.4nm WAFERS: While TSMC is gearing up to expand its overseas production, it would also continue to invest in Taiwan, company chairman and CEO C.C. Wei said Taiwan Semiconductor Manufacturing Co (TSMC) has applied for permission to construct a new plant in the Central Taiwan Science Park (中部科學園區), which it would use for the production of new high-speed wafers, the National Science and Technology Council said yesterday. The council, which supervises three major science parks in Taiwan, confirmed that the Central Taiwan Science Park Bureau had received an application on Friday from TSMC, the world’s largest contract chipmaker, to commence work on the new A14 fab. A14 technology, a 1.4 nanometer (nm) process, is designed to drive artificial intelligence transformation by enabling faster computing and greater power
RSS